Genetic Technologies Embraces Corporate Governance Standards

Genetic Technologies (GENE) has released an update.

Genetic Technologies Ltd has fully complied with the ASX Corporate Governance Council’s recommendations for the reporting period ending June 30, 2024, as detailed in their corporate governance statement. This information, along with their board charter and diversity policy, is available on their website for investor review. The company’s adherence to these governance standards is current as of September 30, 2024, and has been formally approved by the board.

For further insights into GENE stock, check out TipRanks’ Stock Analysis page.